Avery Therapeutics
Tucson, US · Founded 2015 · Arizona corporation · 9 employees on LinkedIn
Founders & leadership
Avery Therapeutics was founded in 2015 by Jennifer Koevary, Steven Goldman, and Jordan Lancaster.
JK
Jennifer KoevaryCo-founder
SG
Steven GoldmanCo-founder
JL
Jordan LancasterCo-founder
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2017
▶$500KraisedJun 2017 · 16 investors · Other TechnologyRule 506(b)
▶$500KraisedJun 2017 · 16 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jennifer KoevaryExecutive Officer
- Steven GoldmanExecutive Officer
- Jordan LancasterExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $500K
- Minimum investment
- $25K
- First sale
- May 2017
- Incorporated
- Corporation, Arizona, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Veratx7 shared keywordsVera Therapeutics develops medicines targeting autoimmune-driven kidney diseases, with a focus on reducing the need for dialysis or transplant. The company was founded by a physician and operates as a clinical-stage biotech with a patient-centered approach to drug development.
Relay7 shared keywordsRelay Therapeutics develops small-molecule therapeutics using its Dynamo platform, which combines experimental and computational methods to model protein motion and target proteins considered difficult to drug. Its pipeline focuses on precision oncology and genetic disease.
Companies competing with Avery Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $484K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded Avery Therapeutics?
- Avery Therapeutics was founded by Jennifer Koevary, Steven Goldman, Jordan Lancaster in 2015.
- How much funding has Avery Therapeutics raised?
- Avery Therapeutics has disclosed $500K raised across 1 round.
- Where is Avery Therapeutics headquartered?
- Avery Therapeutics is headquartered in Tucson, US.